VANGUARD GROUP INC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$9,954,604
-24.4%
2,868,762
+1.4%
0.00%
Q2 2023$13,159,072
+2.6%
2,829,908
+1.9%
0.00%
Q1 2023$12,829,564
-40.0%
2,776,962
+5.0%
0.00%
-100.0%
Q4 2022$21,368,950
+87.8%
2,644,672
+29.0%
0.00%
Q3 2022$11,379,000
+7.2%
2,050,276
+0.6%
0.00%
Q2 2022$10,614,000
-42.1%
2,037,325
-8.7%
0.00%
Q1 2022$18,338,000
-41.8%
2,230,997
+5.3%
0.00%
-100.0%
Q4 2021$31,513,000
-21.1%
2,117,807
+0.1%
0.00%0.0%
Q3 2021$39,952,000
+4.2%
2,115,031
+2.5%
0.00%0.0%
Q2 2021$38,355,000
-17.4%
2,063,195
+1.1%
0.00%0.0%
Q1 2021$46,431,000
+11.2%
2,039,989
+6.0%
0.00%0.0%
Q4 2020$41,761,000
+219.7%
1,923,619
+48.0%
0.00%
Q3 2020$13,064,000
+68.5%
1,299,805
+30.1%
0.00%
Q2 2020$7,753,000
+101.0%
998,965
+164.2%
0.00%
Q1 2020$3,857,000
+3.0%
378,178
+11.0%
0.00%
Q4 2019$3,746,000
+27.5%
340,587
+5.3%
0.00%
Q3 2019$2,939,000
+32.3%
323,299
+65.6%
0.00%
Q2 2019$2,222,000
+10.4%
195,254
+10.5%
0.00%
Q1 2019$2,013,000
+79.6%
176,772
+42.2%
0.00%
Q4 2018$1,121,000124,2830.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,824,542$39,611,00019.08%
Samsara BioCapital, LLC 1,675,579$36,377,0003.66%
SILVERARC CAPITAL MANAGEMENT, LLC 185,000$4,016,0002.33%
Affinity Asset Advisors, LLC 200,000$4,342,0002.30%
Altium Capital Management LP 276,719$6,008,0002.24%
FRAZIER MANAGEMENT LLC 1,001,421$21,741,0001.67%
BVF INC/IL 1,854,162$40,254,0001.58%
Asymmetry Capital Management, L.P. 157,583$3,421,0001.56%
Parkman Healthcare Partners LLC 266,645$5,789,0001.48%
AJU IB Investment Co., Ltd. 175,000$3,799,0001.44%
View complete list of SUTRO BIOPHARMA INC shareholders